Overview

Incretin Regulation of Insulin Secretion in Monogenic Diabetes

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the mechanisms of metabolic control in monogenic diabetes patients treated with sulfonylurea medications.
Phase:
Phase 1
Details
Lead Sponsor:
University of Chicago
Treatments:
Glucagon
Glucagon-Like Peptide 1
Incretins